Perrigo Swings To Earnings In Q2; Reaffirms FY26 Outlook; Shares Surge In Pre-market
Perrigo Co. plc (PRGO) reported Q2 profit despite lower sales. Net income was $74.5M versus a $8.4M loss a year earlier. EPS was $0.53 versus a loss of $0.06. Net sales fell to $1.02B from $1.06B. Perrigo reaffirmed FY2026 outlook, with adjusted EPS of $2.00 to $2.30. Shares rose about 11% premarket to $12.
How this was made
The 30-second read
Why it matters
Q2 profitability improved versus the prior year, and management reaffirmed FY26 guidance with a defined adjusted EPS range, driving a sizable pre-market move.
Market read
Traders can reassess near-term valuation and positioning based on the specific EPS print, adjusted EPS trend, and the reaffirmed FY26 range, alongside the reported 11% pre-market jump.
What to watch
Net sales declined year over year and operating income fell materially, so traders may need to watch whether the reaffirmed FY26 sales growth deceleration to 1.5% reflects a structural demand issue rather than normalization.
Background
Perrigo is a consumer self-care products provider, and the article frames its Q2 performance versus the prior year and reiterates FY26 expectations.
Ticker impact
Perrigo reported Q2 EPS of $0.53 and reaffirmed FY26 guidance, with net sales growth expected to slow to 1.5% and adjusted EPS $2.00 to $2.30.
Bias toward continued pre-market strength, with follow-through dependent on whether investors focus more on EPS improvement or the sales decline and adjusted EPS softness.
The article provides concrete Q2 profitability metrics and a specific FY26 adjusted EPS range, plus an 11% pre-market move, indicating the market is reacting to the earnings and guidance package.
Market effects
Signals resilience in consumer self-care profitability even as sales growth moderates, which can influence sentiment for defensive healthcare consumer product peers.
Primarily US-listed sentiment via NYSE pre-market reaction; limited direct regional spillover described.
No explicit global macro or international regulatory drivers mentioned beyond company-specific guidance.
Counterpoint
The headline EPS improvement may be less compelling if adjusted EPS and operating income are still down, suggesting the market may be over-weighting one-off or continuing-ops effects.
Key entities
- public_companyPerrigo Co. plc
Reported Q2 net income of $74.5M, EPS of $0.53, and reaffirmed FY26 guidance including adjusted EPS of $2.00 to $2.30.
